The survivin mRNA expression positive rate in the de novo and relapse groups, and PML/RARα fusion gene L-type positive groups was obviously higher than those in remission period groups (P < 0.05) and was obviously lower than those in acute leukemia grougs (P < 0.05, <0.001). The gene discussed is RARA; the disease is acute leukemia.